Indogulf Cropsciences Q1 Results: Net Profit Down 38% YoY; EBITDA Margin Rises to 5.7%
Indogulf Cropsciences reported a Q1 consolidated net profit of ₹24.14 million, down 37.6% YoY from ₹38.67 million, as consolidated revenue fell 11% to ₹1,685.45 million. EBITDA stood at ₹96 million versus ₹99 million in the year-ago period, while EBITDA margin improved slightly to 5.7% from 5.24%. Rising raw material costs and higher finance charges weighed on profitability despite marginal improvement in operating efficiency.

*this image is generated using AI for illustrative purposes only.
Indogulf Cropsciences Limited reported a consolidated net profit of ₹24.14 million for the quarter ended June 30, 2026, marking a 37.6% decline from the ₹38.67 million profit recorded in Q1FY25. Despite the drop in profitability, the company's EBITDA came in at ₹96 million versus ₹99 million in the year-ago period, while EBITDA margin improved slightly to 5.7% from 5.24% year-on-year. The contraction in earnings reflects broader margin pressures within the agro-chemical sector, where rising input costs have outpaced revenue generation.
The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on August 12, 2026, at the company's registered office in New Delhi. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Devesh Parekh & Co., in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors issued an unmodified opinion on the financial statements.
Consolidated revenue from operations stood at ₹1,685.45 million for Q1FY26, down 11% year-on-year from ₹1,893.72 million. Standalone revenue also contracted by 12.3% to ₹1,623.96 million, compared to ₹1,851.38 million in the corresponding quarter of the previous fiscal year. Other income decreased marginally to ₹8.85 million on a consolidated basis, while standalone other income rose slightly to ₹14.00 million.
Financial Performance Breakdown
The following table summarises the key financial metrics across consolidated and standalone bases for Q1FY26 and Q1FY25:
| Metric | Consolidated Q1FY26 | Consolidated Q1FY25 | Standalone Q1FY26 | Standalone Q1FY25 |
|---|---|---|---|---|
| Revenue from Operations (₹ Million) | 1,685.45 | 1,893.72 | 1,623.96 | 1,851.38 |
| Total Income (₹ Million) | 1,694.30 | 1,903.05 | 1,637.96 | 1,861.69 |
| Total Expenses (₹ Million) | 1,662.75 | 1,856.67 | 1,608.88 | 1,825.69 |
| EBITDA (₹ Million) | 96.00 | 99.00 | — | — |
| EBITDA Margin (%) | 5.70 | 5.24 | — | — |
| Profit Before Tax (₹ Million) | 31.24 | 46.49 | 28.77 | 36.11 |
| Net Profit (₹ Million) | 24.14 | 38.67 | 22.69 | 29.54 |
| EPS Basic (₹) | 0.38 | 0.80 | 0.36 | 0.61 |
The company's total consolidated expenses amounted to ₹1,662.75 million, with the cost of raw material and components consumed being the largest component at ₹1,465.84 million. Employee benefits expense rose to ₹137.13 million from ₹126.71 million in the year-ago period. Finance costs increased to ₹45.10 million from ₹37.85 million. Standalone expenses followed a similar pattern, totaling ₹1,608.88 million.
What the Numbers Show
A key observation from the Q1FY26 results is the divergence between revenue decline and expense behaviour. While consolidated revenue fell by approximately 11%, the absolute value of total expenses decreased by only 10.4%. The structure of expenses reveals pressure points: the cost of raw materials remained high relative to output, compressing margins. The profit before tax dropped sharply from ₹46.49 million to ₹31.24 million, indicating that fixed costs and financing charges did not decrease proportionally with the dip in sales. Notably, EBITDA margin expanded to 5.7% from 5.24% year-on-year, suggesting some improvement in operating efficiency even as absolute EBITDA slipped from ₹99 million to ₹96 million. Additionally, exceptional items recorded a loss of ₹0.31 million due to the disposal of fixed assets, further impacting the bottom line. The foreign subsidiary, Indogulf Cropsciences Australia Pty Ltd., contributed unaudited financial information which management deemed not material to the group's overall results.
Historical Stock Returns for Indogulf Cropsciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.36% | -4.81% | -4.99% | -3.85% | -32.69% | -35.06% |
What specific strategies is Indogulf Cropsciences planning to implement to offset rising raw material costs and restore revenue growth in Q2FY26?
How will the increasing finance costs, which rose to ₹45.10 million, impact the company's debt servicing capacity and future capital allocation decisions?
Given the 11% revenue decline, does management anticipate a seasonal recovery in agro-chemical demand later in FY26, or is this indicative of a structural market downturn?


































